Gilman Hill Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$307K Hold
846
0.04% 190
2026
Q1
$298K Buy
846
+5
+0.6% +$1.78K 0.05% 186
2025
Q4
$275K Hold
841
0.04% 191
2025
Q3
$237K Buy
841
+7
+0.8% +$2.03K 0.04% 206
2025
Q2
$233K Buy
834
+86
+11% +$24.4K 0.04% 202
2025
Q1
$233K Buy
+748
New +$221K 0.04% 193
2024
Q4
Sell
-748
Closed -$241K 220
2024
Q3
$241K Hold
748
0.04% 195
2024
Q2
$234K Sell
748
-900
-55% -$264K 0.04% 189
2024
Q1
$469K Sell
1,648
-40
-2% -$11.7K 0.08% 137
2023
Q4
$486K Buy
1,688
+31
+2% +$8.45K 0.09% 136
2023
Q3
$445K Hold
1,657
0.09% 139
2023
Q2
$368K Sell
1,657
-20
-1% -$4.64K 0.07% 155
2023
Q1
$406K Sell
1,677
-110
-6% -$27K 0.08% 144
2022
Q4
$469K Hold
1,787
0.1% 140
2022
Q3
$403K Hold
1,787
0.09% 147
2022
Q2
$435K Sell
1,787
-5,344
-75% -$1.31M 0.09% 141
2022
Q1
$1.73M Buy
7,131
+282
+4% +$64.8K 0.39% 76
2021
Q4
$1.54M Sell
6,849
-320
-4% -$67.5K 0.34% 82
2021
Q3
$1.52M Buy
7,169
+485
+7% +$112K 0.39% 74
2021
Q2
$1.63M Buy
6,684
+1,186
+22% +$292K 0.42% 71
2021
Q1
$1.37M Buy
5,498
+600
+12% +$143K 0.38% 73
2020
Q4
$1.13M Buy
4,898
+854
+21% +$197K 0.37% 79
2020
Q3
$1.03M Sell
4,044
-762
-16% -$189K 0.4% 69
2020
Q2
$1.13M Sell
4,806
-95
-2% -$21.7K 0.45% 61
2020
Q1
$994K Sell
4,901
-68
-1% -$14.9K 0.48% 65
2019
Q4
$1.2M Sell
4,969
-518
-9% -$114K 0.39% 68
2019
Q3
$1.06M Sell
5,487
-1,595
-23% -$306K 0.35% 72
2019
Q2
$1.3M Buy
7,082
+2,285
+48% +$409K 0.44% 60
2019
Q1
$911K Sell
4,797
-155
-3% -$29.6K 0.32% 77
2018
Q4
$964K Sell
4,952
-315
-6% -$61.5K 0.41% 67
2018
Q3
$1.09M Sell
5,267
-260
-5% -$51.2K 0.43% 63
2018
Q2
$1.02M Buy
5,527
+560
+11% +$99.1K 0.42% 62
2018
Q1
$847K Buy
4,967
+895
+22% +$164K 0.37% 69
2017
Q4
$708K Sell
4,072
-65
-2% -$11.5K 0.29% 85
2017
Q3
$771K Buy
4,137
+225
+6% +$39.9K 0.32% 78
2017
Q2
$674K Sell
3,912
-1,800
-32% -$293K 0.29% 83
2017
Q1
$937K Sell
5,712
-589
-9% -$97.9K 0.41% 55
2016
Q4
$921K Buy
6,301
+1,796
+40% +$270K 0.34% 55
2016
Q3
$751K Buy
4,505
+94
+2% +$15.9K 0.29% 65
2016
Q2
$671K Buy
4,411
+41
+0.9% +$6.37K 0.28% 70
2016
Q1
$655K Sell
4,370
-775
-15% -$115K 0.3% 69
2015
Q4
$835K Sell
5,145
-45
-0.9% -$7.07K 0.4% 54
2015
Q3
$718K Buy
5,190
+419
+9% +$66K 0.37% 59
2015
Q2
$732K Buy
4,771
+2,170
+83% +$348K 0.35% 64
2015
Q1
$416K Buy
2,601
+98
+4% +$15.4K 0.2% 99
2014
Q4
$399K Sell
2,503
-298
-11% -$46.4K 0.2% 96
2014
Q3
$393K Buy
2,801
+170
+6% +$22.2K 0.21% 94
2014
Q2
$311K Buy
2,631
+331
+14% +$38.3K 0.16% 111
2014
Q1
$284K Buy
+2,300
New +$279K 0.17% 104

Other funds holding AMGN

Gilman Hill Asset Management's AMGN Position: Q2 2026 in Review

Gilman Hill Asset Management held its Amgen (AMGN) position steady in Q2 2026 at 846 shares worth $307K. The position accounts for 0.04% of the portfolio, ranked #190.

Gilman Hill Asset Management first reported a position in AMGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.73M in Q1 2022. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gilman Hill Asset Management held 846 shares of Amgen worth $307K as of Q2 2026.
  • Gilman Hill Asset Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.04% of Gilman Hill Asset Management's portfolio in Q2 2026, its #190 holding.
  • Gilman Hill Asset Management first reported a position in Amgen in Q1 2014 and has held it in 49 quarters since.
  • Gilman Hill Asset Management's Amgen position peaked at $1.73M in Q1 2022.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.